Research Calls
- Upgrades:
- Applied Materials (AMAT) upgraded to Buy from Hold at Summit Insights
- Domino's Pizza (DPZ) upgraded to Buy from Neutral at Northcoast; tgt $460
- Pinnacle West (PNW) upgraded to Neutral from Sell at Guggenheim; tgt raised to $70
- Ross Stores (ROST) upgraded to Buy from Hold at Gordon Haskett; tgt $130
- Downgrades:
- Coinbase Global (COIN) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $50
- Chart Industries (GTLS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $133
- Editas Medicine (EDIT) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $13
- Editas Medicine (EDIT) downgraded to Perform from Outperform at Oppenheimer; tgt lowered to $12
- HP Inc. (HPQ) downgraded to Neutral from Outperform at Credit Suisse
- RH (RH) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $270
- Others:
- 4D Molecular Therapeutics (FDMT) initiated with a Buy at H.C. Wainwright; tgt $36
- AbbVie (ABBV) initiated with an Outperform at Credit Suisse; tgt $170
- Akili Inc. (AKLI) initiated with a Neutral at BofA Securities; tgt $2
- Amgen (AMGN) initiated with an Underperform at Credit Suisse; tgt $240
- Arcus Biosciences (RCUS) initiated with a Neutral at BofA Securities; tgt $33
- Bristol-Myers (BMY) initiated with a Neutral at Credit Suisse; tgt $78
- Conagra (CAG) upgraded to Buy from Neutral at UBS; tgt raised to $41
- CoStar Group (CSGP) resumed with a Buy at BofA Securities; tgt $100
- DraftKings (DKNG) initiated with an Overweight at Piper Sandler; tgt $21
- Dragonfly Energy (DFLI) initiated with a Buy at Chardan Capital Markets; tgt $15
- Eli Lilly (LLY) initiated with an Outperform at Credit Suisse; tgt $395
- Fulgent Genetics (FLGT) initiated with an Outperform at Raymond James; tgt $45
- Insmed (INSM) initiated with a Buy at BofA Securities; tgt $39
- Johnson & Johnson (JNJ) initiated with a Neutral at Credit Suisse; tgt $170
- Merck (MRK) initiated with an Outperform at Credit Suisse; tgt $120
- NeoGames (NGMS) initiated with an Underperform at BofA Securities; tgt $16
- Pfizer (PFE) initiated with an Outperform at Credit Suisse; tgt $55
- Precigen (PGEN) initiated with an Overweight at Cantor Fitzgerald; tgt $7